Preventing antibodies to infliximab in patients with Crohn's disease: optimize not immunize

Gastroenterology. 2003 Apr;124(4):1140-5. doi: 10.1053/gast.2003.50182.
No abstract available

Publication types

  • Comment
  • Editorial
  • Review

MeSH terms

  • Anti-Inflammatory Agents / administration & dosage*
  • Antibodies / blood
  • Antibodies, Monoclonal / administration & dosage
  • Antibodies, Monoclonal / immunology*
  • Crohn Disease / drug therapy*
  • Crohn Disease / immunology
  • Gastrointestinal Agents / administration & dosage
  • Gastrointestinal Agents / immunology*
  • Humans
  • Hydrocortisone / administration & dosage*
  • Infliximab

Substances

  • Anti-Inflammatory Agents
  • Antibodies
  • Antibodies, Monoclonal
  • Gastrointestinal Agents
  • Infliximab
  • Hydrocortisone